373 related articles for article (PubMed ID: 28160247)
1. Adenocarcinoma arising in multiple hyperplastic polyps in a patient with Helicobacter pylori infection and hypergastrinemia during long-term proton pump inhibitor therapy.
Anjiki H; Mukaisho KI; Kadomoto Y; Doi H; Yoshikawa K; Nakayama T; Vo DT; Hattori T; Sugihara H
Clin J Gastroenterol; 2017 Apr; 10(2):128-136. PubMed ID: 28160247
[TBL] [Abstract][Full Text] [Related]
2. Malignant transformation of a gastric hyperplastic polyp in a context of Helicobacter pylori-negative autoimmune gastritis: a case report.
Yamanaka K; Miyatani H; Yoshida Y; Ishii T; Asabe S; Takada O; Nokubi M; Mashima H
BMC Gastroenterol; 2016 Oct; 16(1):130. PubMed ID: 27729029
[TBL] [Abstract][Full Text] [Related]
3. Safety of proton pump inhibitors and risk of gastric cancers: review of literature and pathophysiological mechanisms.
Ko Y; Tang J; Sanagapalli S; Kim BS; Leong RW
Expert Opin Drug Saf; 2016 Jan; 15(1):53-63. PubMed ID: 26560097
[TBL] [Abstract][Full Text] [Related]
4. Long-term proton pump inhibitor administration worsens atrophic corpus gastritis and promotes adenocarcinoma development in Mongolian gerbils infected with Helicobacter pylori.
Hagiwara T; Mukaisho K; Nakayama T; Sugihara H; Hattori T
Gut; 2011 May; 60(5):624-30. PubMed ID: 21097844
[TBL] [Abstract][Full Text] [Related]
5. Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology.
Lundell L; Vieth M; Gibson F; Nagy P; Kahrilas PJ
Aliment Pharmacol Ther; 2015 Sep; 42(6):649-63. PubMed ID: 26177572
[TBL] [Abstract][Full Text] [Related]
6. Hypergastrinemia in Long-Term Use of Proton Pump Inhibitors.
Shiotani A; Katsumata R; Gouda K; Fukushima S; Nakato R; Murao T; Ishii M; Fujita M; Matsumoto H; Sakakibara T
Digestion; 2018; 97(2):154-162. PubMed ID: 29310112
[TBL] [Abstract][Full Text] [Related]
7. Enterocromaffin-like cell tumor induced by Helicobacter pylori infection in Mongolian gerbils.
Kagawa J; Honda S; Kodama M; Sato R; Murakami K; Fujioka T
Helicobacter; 2002 Dec; 7(6):390-7. PubMed ID: 12485127
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic, histological and serologic findings of gastric hyperplastic polyps after eradication of Helicobacter pylori: comparison between responder and non-responder cases.
Ohkusa T; Miwa H; Hojo M; Kumagai J; Tanizawa T; Asaoka D; Terai T; Ohkura R; Sato N
Digestion; 2003; 68(2-3):57-62. PubMed ID: 14581761
[TBL] [Abstract][Full Text] [Related]
9. Serum gastrin and chromogranin A levels in patients with fundic gland polyps caused by long-term proton-pump inhibition.
Fossmark R; Jianu CS; Martinsen TC; Qvigstad G; Syversen U; Waldum HL
Scand J Gastroenterol; 2008 Jan; 43(1):20-4. PubMed ID: 18938772
[TBL] [Abstract][Full Text] [Related]
10. Effects of Proton Pump Inhibitor Therapy,
Veysey-Smith R; Moore AR; Murugesan SV; Tiszlavicz L; Dockray GJ; Varro A; Pritchard DM
Front Endocrinol (Lausanne); 2021; 12():741887. PubMed ID: 34867785
[TBL] [Abstract][Full Text] [Related]
11. Gastric Hyperplastic Polyps Associated with Proton Pump Inhibitor Use in a Case without a History of Helicobacter pylori Infection.
Miyamoto S; Kato M; Matsuda K; Abiko S; Tsuda M; Mizushima T; Yamamoto K; Ono S; Kudo T; Shimizu Y; Hatanaka KC; Tsunematsu I; Sakamoto N
Intern Med; 2017; 56(14):1825-1829. PubMed ID: 28717077
[TBL] [Abstract][Full Text] [Related]
12. Incidence and risk factor of fundic gland polyp and hyperplastic polyp in long-term proton pump inhibitor therapy: a prospective study in Japan.
Hongo M; Fujimoto K;
J Gastroenterol; 2010 Jun; 45(6):618-24. PubMed ID: 20177714
[TBL] [Abstract][Full Text] [Related]
13. Severe Anemia from Multiple Gastric Hyperplastic Polyps in a Hemodialysis Patient after Long-term Use of a Proton-pump Inhibitor.
Ikeda S; Takahashi T; Tandoh T; Ushiyama K; Kida Y
Intern Med; 2024; 63(5):649-657. PubMed ID: 38432892
[TBL] [Abstract][Full Text] [Related]
14. Old and New Gut Hormone, Gastrin and Acid Suppressive Therapy.
Haruma K; Kamada T; Manabe N; Suehiro M; Kawamoto H; Shiotani A
Digestion; 2018; 97(4):340-344. PubMed ID: 29587283
[TBL] [Abstract][Full Text] [Related]
15. Importance of gastrin in the pathogenesis and treatment of gastric tumors.
Burkitt MD; Varro A; Pritchard DM
World J Gastroenterol; 2009 Jan; 15(1):1-16. PubMed ID: 19115463
[TBL] [Abstract][Full Text] [Related]
16. Proton pump inhibitors and helicobacter pylori-associated pathogenesis.
Hagiwara T; Mukaisho K; Nakayama T; Hattori T; Sugihara H
Asian Pac J Cancer Prev; 2015; 16(4):1315-9. PubMed ID: 25743791
[TBL] [Abstract][Full Text] [Related]
17. Extreme hypergastrinemia caused by atrophic gastritis and Helicobacter pylori infection--a case report.
Huang SM; Lin HH; Wen TY; Hsu YH
Hepatogastroenterology; 2001; 48(40):1215-6. PubMed ID: 11490838
[TBL] [Abstract][Full Text] [Related]
18. Gastric cancer and gastrin: on the interaction of Helicobacter pylori gastritis and acid inhibitory induced hypergastrinemia.
Waldum HL; Rehfeld JF
Scand J Gastroenterol; 2019 Sep; 54(9):1118-1123. PubMed ID: 31524029
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori infection and fasting serum gastrin levels in a series of endoscopically diagnosed gastric polyps.
Varis O; Laxén F; Valle J
APMIS; 1994 Oct; 102(10):759-64. PubMed ID: 7826605
[TBL] [Abstract][Full Text] [Related]
20. Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status.
Hansen S; Vollset SE; Derakhshan MH; Fyfe V; Melby KK; Aase S; Jellum E; McColl KE
Gut; 2007 Jul; 56(7):918-25. PubMed ID: 17317788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
